glp-1 news november 6 2025 Weight-loss drug makers announce pricing agreement with Trump As GLP-1 Drugs Go Mainstream,

A growing number of lawsuits now allege that Ozempic, Wegovy, and Mounjaro caused nonarteritic anterior ischemic optic neuropathy (NAION), a rare condition linked to sudden vision loss

Building your personalized injection site protocol Now let us put everything together into a practical, personalized strategy you can implement starting with your next injection

The Research Behind This Article: Chowdhury et al

The primary outcomes were safety and tolerability, assessed by the incidence, severity, and causality of adverse events and by changes in clinical laboratory parameters and physical examinations

By introducing access to generic semaglutide in Canada, the company is meeting the needs of a dynamic market and continuing its international expansion efforts Nearly two-thirds of Canadian adults are overweight or living with obesity, but cost has remained a significant barrier to access the treatment they need